Skip to main content
. 2019 May 20;6:2329048X19848181. doi: 10.1177/2329048X19848181

Figure 3.

Figure 3.

Magnetic resonance imaging (MRI) examination performed 18 months later, after rituximab administration. T2-weighted images. Focal hyperintense lesion in the right cerebral hemisphere and small cystic lesions on the left side. Note diffuse cerebral atrophy. Progression of lesions.